Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

braxia

Braxia Scientific (BRAX.C) announced they will be conducting a randomized clinical trial that will involve giving patients multiple doses of psilocybin. Braxia says this is Canada’s first psilocybin trial…
Braxia Scientific (BRAX.C) filed their Q4 and full year-end results for the three and twelve month periods ending on March 31, 2021. At the end of March 2021, Braxia…
Braxia Scientific’s (BRAX.C) CEO Dr. Roger McIntyre and Chief Medical and Scientific Officer Dr. Josh Rosenblat have received $918,000 from the Canadian Institutes of Health Research (CIHR), the Government of Canada’s federal funding agency…
Braxia Scientific (BRAX.C) announced that they have established direct billing practices with Medavie Blue Cross for qualifying Canadian military veterans. This agreement is significant because it will allow 100%…
Esketamine Braxia Scientific (BRAX.C), formerly known as Champignon Brands had a rough 2020. It was a down year for many of us, but Champignon really found itself in trouble…